Nagasaka K

No ORCID on file · 4 papers in corpus · active 2022-2025

Study types

  • article 1
  • case-report 1

Condition tags

  • endometriosis 1
  • chronic_pelvic_pain 1
  • infertility 1
  • adenomyosis 1
case-report 2025
Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series
BMC women's health ·doi:10.1186/s12905-025-03681-8

BACKGROUND: Adenomyosis, characterized by endometrial tissue within the uterine muscle, often presents with severe pelvic pain and menorrhagia. This case series demonstrates the efficacy of sequential therapy involving relugolix followed by…

2024
Prognostic analysis of peritoneal washing cytology during interval debulking surgery in advanced ovarian cancer.
Journal of ovarian research ·doi:10.1186/s13048-024-01494-1

BackgroundInterval debulking surgery (IDS) following neoadjuvant chemotherapy is a treatment option for advanced ovarian cancer. Optimal surgery is required for better survival; however, while peritoneal washing cytology (PWC) has been iden…

article 2024
Proposal for individual treatment by tubal occlusion factor based on the results of salpingoscopic salpingoplasty
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15993

AIM: As a treatment for tubal infertility, falloposcopic tuboplasty (FT) is one of the options for patients who wish to conceive naturally. Based on the results of FT, we propose an appropriate time of transitioning to assisted reproductive…

2022
Case report: Posterior reversible encephalopathy syndrome, an adverse effect of lenvatinib and pembrolizumab combination therapy, in a patient with advanced endometrial cancer.
Frontiers in oncology ·doi:10.3389/fonc.2022.1079716

BackgroundLenvatinib-pembrolizumab combination (LEAP) is an approved therapy in Japan for advanced endometrial cancer, based on the data from the KEYNOTE-775 clinical trial. We report a case of posterior reversible encephalopathy syndrome (…